OOIR: Observatory of International Research

Papers

(The median citation count of Archiv der Pharmazie is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
In vitro antiviral activity of favipiravir and its 6‐ and 3‐O‐substituted derivatives against coronavirus: Acetylation leads to improvement of antiviral activity	69
Cover Picture: Arch Pharm (1/2024)	68
What doesn't fit is made to fit: Pim‐1 kinase adapts to the configuration of stilbene‐based inhibitors	58
Aripiprazole as an Inhibitor of the EGFR/PI3K/AKT Signaling Pathway and Sensitizer of MPA Suppressed Progestin‐Resistant Endometrial Cancer Cells	56
Design, synthesis, and activity evaluation of novel multitargeted l‐tryptophan derivatives with powerful antioxidant activity against Alzheimer's disease	50
Medicinal Chemistry, SAR, and Molecular Insights Into 2,4‐Thiazolidinediones as Antidiabetic Agents (2020–2025)	48
Functional combination of resveratrol and tamoxifen to overcome tamoxifen‐resistance in breast cancer cells	43
Selective cytotoxicity of ent‐kaurene diterpenoids isolated from Baccharis lateralis and Baccharis retusa (Asteraceae)	40
Synthesis and biological evaluation of salophen nickel(II) and cobalt(III) complexes as potential anticancer compounds	38
Synthesis and Biological Evaluation of Novel 2‐(Piperidin‐4‐yl)‐1,2,3,4‐tetrahydroisoquinoline and 2‐(Piperidin‐4‐yl)decahydroisoquinoline Antimycotics	33
Isoxazole‐Based Compounds Targeting the Taxane‐Binding Site of Tubulin	33
Discovery of xanthone‐based nitric oxide donors targeting biofilm clearance	32
Investigating the Hepatoprotective Properties of Entresto in Hepatic Ischemia‐Reperfusion Injury in Rats: The Implication of TLR4/MYD88/NF‐KB p‐65 and PPAR‐γ/HO‐1/Nrf2 Pathways	31
AI‐Based Prediction of PROTAC‐ and Molecular Glue‐Mediated Ternary Complexes: A Comparative Evaluation of AlphaFold 3 and Boltz‐2	31
GOAT rs10096097 and CREB1 rs6740584 single nucleotide polymorphisms are associated with type 2 diabetes mellitus in Egyptians	29
Fabrication of sulfobutylether‐β‐cyclodextrin/glabridin inclusion complex for promoting bioactivities	28
Combating DC‐SIGN‐mediated SARS‐CoV‐2 dissemination by glycan‐mimicking polymers	26
NorA Efflux Pump Inhibitors: Expanding SAR Knowledge of Pyrazolo[4,3‐c][1,2]benzothiazine 5,5‐Dioxide Derivatives	25
Issue Information: Arch Pharm (1/2026)	24
Ultra‐Fast UPLC‐MS/MS Method for the Ripretinib Quantification in the HLMs Matrix With Metabolic Stability Assessment: In‐Silico Study for Toxic Alerts and the Metabolic Lability	24
Synthesis, density functional theory calculation, molecular docking studies, and evaluation of novel 5‐nitrothiophene derivatives for anticancer activity	23
Synthesis of novel pyrimido[4,5‐b]quinoline derivatives as dual EGFR/HER2 inhibitors as anticancer agents	23
Synthesis, antimycobacterial, cytotoxicity, anti‐inflammatory, in silico studies and molecular dynamics of pyrazole‐embedded thiazolidin‐4‐one hybrids	23
Unraveling the Anticancer Activity of Sunitinib Derivatives Through Modifications in Solvent‐Exposed Regions: Synthesis, In Vitro Evaluation, and Computational Studies	23
Piperlongumine and its derivatives against cancer: A recent update and future prospective	22

Carboline Hybrids as Potential Multitarget‐Directed Anti‐Alzheimer's Disease Agents: A Comprehensive Analysis of Design Strategies and Structure–Activity Relationships	22
Review on the pharmacological effects and pharmacokinetics of scutellarein	22
	21
Chemistry of heterocycles as carbonic anhydrase inhibitors: A pathway to novel research in medicinal chemistry review	21
Structure‐guided identification of a selective sulfonamide‐based inhibitor targeting the human carbonic anhydrase VA isoform	21
Thiazole‐based SARS‐CoV‐2 protease (COV M^pro) inhibitors: Design, synthesis, enzyme inhibition, and molecular modeling simulations	21
	21
DCAF16‐Based Covalent Molecular Glues for Targeted Protein Degradation of Histone Deacetylases	21
Replacing the oxidation‐sensitive triaminoaryl chemotype of problematic K_V7 channel openers: Exploration of a nicotinamide scaffold	21
Aromatic linker variations in novel dopamine D₂ and D₃ receptor ligands	20
Cover Picture: Arch Pharm (7/2023)	20
Editorial Board: Arch Pharm (10/2023)	20
Design, synthesis and biological evaluation of (E)‐kojyl‐styryl‐sulfones: Novel recilisib hybrids as promising radioprotectors	20
Microwave‐Enhanced Synthesis of 2‐Styrylquinoline‐4‐Carboxamides With Promising Anti‐Lymphoma Activity	19
Cover Picture: Arch Pharm (2/2024)	19
The discovery of a new nonbile acid modulator of Takeda G protein‐coupled receptor 5: An integrated computational approach	19
Evaluation of the effect of carvedilol orodispersible tablets on ischemia–reperfusion injury and flap viability in rats: An in vivo study	19
Issue Information: Arch Pharm (5/2025)	19
Novel benzothiazole/benzothiazole thiazolidine‐2,4‐dione derivatives as potential FOXM1 inhibitors: In silico, synthesis, and in vitro studies	18
Uncovering chemical profiles, biological potentials, and protection effect against ECM destruction in H₂O₂‐treated HDF cells of the extracts of Stachys tundjeliensis	18
	18
The medicinal perspective of 2,4‐thiazolidinediones based ligands as antimicrobial, antitumor and antidiabetic agents: A review	18
Discover the Power of Lithospermic Acid as Human Carbonic Anhydrase VA and Pancreatic Lipase Inhibitor Through In Silico and In Vitro Studies	18
The Therapeutic Potential of Berberine in Lung Cancer	18
Novel therapeutic strategies and drugs for idiopathic pulmonary fibrosis	17
Liposomal formulation of model pentathiepin improves solubility and stability toward glutathione while preserving anticancer activity	17
Design, synthesis, and evaluation of dual‐target inhibitors for the treatment of Alzheimer's disease	17
Novel tetrahydropyran‐triazole hybrids with antiproliferative activity against human tumor cells	17
Optimization of 4‐amino‐pyridazin‐3(2H)‐one as a valid core scaffold for FABP4 inhibitors	17
New chimeric HDAC inhibitors for the treatment of colorectal cancer	16
Unveiling the Therapeutic Potential of Dulaglutide in Mitigating Tacrolimus‐Induced Nephrotoxicity Through Targeting the miR‐22/HMGB‐1/TLR4/MyD88/NF‐κB Trajectory	16
Spirooxadiazoline‐oxindoles derived from imatinib show antimyeloproliferative potential in K562 cells	16
Structural determinants of sphingosine‐1‐phosphate receptor selectivity	16
Green Synthetic Strategies for Pyrazole Derivatives: A Comprehensive Review	16
Combining chemical profiles and biological abilities of different extracts from Tanacetum nitens (Boiss. & Noë) Grierson using network pharmacology	16
Exploration of 3‐aryl pyrazole‐tethered sulfamoyl carboxamides as carbonic anhydrase inhibitors	16
Discovery of novel pyrazole and pyrazolo[1,5‐a]pyrimidine derivatives as cyclooxygenase inhibitors (COX‐1 and COX‐2) using molecular modeling simulation	15
Design, synthesis, and biological evaluation of simplified tetrahydroisoquinoline analogs	15
Quantum dots in the biomedical world: A smart advanced nanocarrier for multiple venues application	15
Peripheral (E)‐2‐[(4‐hydroxybenzylidene)‐3,4‐dihydronaphthalen‐1(2H)‐one)]‐coordinated phthalocyanines with improved enzyme inhibition properties and photophysicochemical behaviors	15
Fully Synthetic Non‐Carbohydrate Heparin Mimetics—Perspectives for Therapeutic Anticoagulation and Beyond?	15
Cover Picture: Arch Pharm (6/2022)	15
Implication of Central β₂ Adrenergic Receptor for the Development of Novel Drugs Against Alzheimer's Disease	15
Design, synthesis, biological evaluation, and molecular modeling simulations of new phthalazine‐1,4‐dione derivatives as anti‐Alzheimer's agents	15
Unprecedented carbonic anhydrase inhibition mechanism: Targeting histidine 64 side chain through a halogen bond	15
5‐methyl‐2‐carboxamidepyrrole‐based novel dual mPGES‐1/sEH inhibitors as promising anticancer candidates	15
	14
Identification of Novel β ‐Lactam Derivatives as Proteasome Inhibitors for Antitumor Therapy	14
Synthesis of new phenothiazine derivatives: Molecular docking, assessment of cytotoxic activity and oxidant–antioxidant properties on PCS‐201‐012, HT‐29, and SH‐SY5Y cell lines	14
Exploring the Antidiabetic Potential of Heterophylliin A From Elaeocarpus grandis	14

N‐[4‐(Benzyloxy)‐3‐methoxybenzyl)]adamantane‐1‐amine (DZH2), a dual CCR5 and CXCR4 inhibitor as a potential agent against triple negative breast cancer	14
Synthesis, Characterization and Evaluation of Antioxidant and Antimicrobial Activities of Novel Isatin Derivatives	14
Conjugates of amiridine and thiouracil derivatives as effective inhibitors of butyrylcholinesterase with the potential to block β‐amyloid aggregation	14
Current scenario of fused pyrimidines with in vivo anticancer therapeutic potential	13
Discovery of potent CSK inhibitors through integrated virtual screening and molecular dynamic simulation	13
Investigating the Telomerase Downregulatory Potential of Steroidal Drugs Following Pharmacophore‐Based Rational; Computational and In Vitro Assessments	13
	13
Unveiling the chemistry of 1,3,4‐oxadiazoles and thiadiazols: A comprehensive review	13
Issue Information: Arch Pharm (4/2025)	13
Identification of 3‐(5‐cyano‐6‐oxo‐pyridin‐2‐yl)benzenesulfonamides as novel anticancer agents endowed with EGFR inhibitory activity	13
Review of β‐carboline and its derivatives as selective MAO‐A inhibitors	13
Harnessing Hybrid Chemistry: Novel Ethyl Ferulate Ester of Niflumic Acid for Enhanced Therapeutic Benefits	13
Cytotoxic derivatives of dichloroacetic acid and some metal complexes	13
	13
Cover Picture: Arch Pharm (6/2023)	13
A literature review on pharmacological aspects, docking studies, and synthetic approaches of quinazoline and quinazolinone derivatives	13
Piperazine‐based P2X4 receptor antagonists	13
Algal–Bacterial Interaction‐Driven Secondary Metabolites From Phaeobacter inhibens and Their Anti‐Allergic Effects on Th2 Cell Immune Response	13
New benzimidazole‐oxadiazole derivatives: Synthesis, α‐glucosidase, α‐amylase activity, and molecular modeling studies as potential antidiabetic agents	13
Hydrazinated geraniol derivatives as potential broad‐spectrum antiprotozoal agents	13
	13
Recent updates on 1,2,3‐, 1,2,4‐, and 1,3,5‐triazine hybrids (2017–present): The anticancer activity, structure–activity relationships, and mechanisms of action	13
Synthesis, Antituberculosis Evaluation and Structure–Activity Relationships of New SQ109 Analogs	12
Synthesis and evaluation of novel almazole D analogs as anticancer agents	12
Synthesis and photodynamic activity of new 5‐[(E)‐2‐(3‐alkoxy‐1‐phenyl‐1H‐pyrazol‐4‐yl)ethenyl]‐2‐phenyl‐3H‐indoles	12
Identification of novel sulfathiazole‐triazolo‐chalcone hybrids as VEGFR‐2/EGFR dual inhibitors with antiangiogenic activity and apoptotic induction	12
Tandem synthesis, cytotoxicity, and in silico study of new 1,3,4‐oxadiazoles as potential thymidylate synthase inhibitors	12
5,6‐Dihydrotetrazolo[1,5‐c]quinazolines: Toxicity prediction, synthesis, antimicrobial activity, molecular docking, and perspectives	12
Therapeutic Horizons in Targeting EZH2 With Dual and Non‐PROTAC Inhibitor Molecules: Recent Achievements, Comparative Analysis, and Future Perspectives	12
A new series of hydrazones as small‐molecule aldose reductase inhibitors	12
New PEPPSI‐Pd‐NHC complexes bearing 4‐hydroxyphenylethyl group: Synthesis, characterization, molecular docking, and bioactivity properties	12
The therapeutic potential of indole hybrids, dimers, and trimers against drug‐resistant ESKAPE pathogens	12
Design, synthesis, and evaluation of novel 3,4‐isoxazolediamide derivatives for the combination treatment of azole‐resistant candidiasis	12
Recent Advancements and Developments of Anti‐Malarial Agents Reported in 2023	12
Screening of Chelidonium majus isoquinoline alkaloids reveals berberine and chelidonine as selective ligands for the nuclear receptors RORβ and HNF4α, respectively	12
A Multifaceted Mechanistic Approach to Assess the Inhibitory Potential of Broccoli‐Derived Glucosinolates Against Tumor‐Associated Carbonic Anhydrase IX	12
Current Landscape of Hydroxamic Acid Hybrids With Anti‐Colorectal Cancer Potential	12
Silybin loaded Ag‐nanoparticles as a drug delivery system for solid tumor theragnosis: Extraction, radioiodination, and biodistribution study	11
Advances in polysaccharide‐based materials for biomedical and pharmaceutical applications: A comprehensive review	11
Development of New Thiadiazole Derivatives as VEGFR‐2 Inhibitors With Anticancer and Proapoptotic Activities‏	11
Novel quinazoline–chromene hybrids as anticancer agents: Synthesis, biological activity, molecular docking, dynamics and ADME studies	11
Design, Synthesis, and Molecular Evaluation of S_NAr‐Reactive N‐(6‐Fluoro‐3‐Nitropyridin‐2‐yl)Isoquinolin‐3‐Amines as Covalent USP7 Inhibitors Reveals an Unconventional Binding Mode	11
Role of Brusatol in Preventing Gastrointestinal Cancer: Recent Trends and Future Perspectives	11
Solvent and Catalyst‐Free One‐Pot Synthesis of Tetrahydropyrimidine Analogs for Their Larvicidal Activity and Structural Insights	11
Current Scenario of Hydroxamic Acid Derivatives With In Vivo Antitumor Therapeutic Potential	11
Design, synthesis, acetylcholinesterase, butyrylcholinesterase, and amyloid‐β aggregation inhibition studies of substituted 4,4ʹ‐diimine/4,4ʹ‐diazobiphenyl derivatives	11
	11
Decoding MYC Targeted Inhibition in Cancer: Integrating Medicinal Insights With Computational Design Approaches	11
Synthesis of novel benzylamine antimycotics and evaluation of their antimycotic potency	11
Unlocking the potential of edible Ulva sp. seaweeds: Metabolomic profiling, neuroprotective mechanisms, and implications for Parkinson's disease management	11
Tetrazole Derivatives as Multiclass Inhibitors of Bacterial Carbonic Anhydrases	11
Issue Information: Arch Pharm (4/2024)	11
A virtual library of small molecules mimicking dipeptides	10
Development of 1‐(2‐aminophenyl)pyrrole‐based amides acting as human topoisomerase I inhibitors	10
Health benefits of fraxetin: From chemistry to medicine	10
Structural Advances in Non‐Sulfonamide Carbonic Anhydrase Inhibitors: Insights Into Design, Bioactivity, and Binding Mechanism	10
New paracetamol hybrids as anticancer and COX‐2 inhibitors: Synthesis, biological evaluation and docking studies	10
Discovery of 4‐(isopentyloxy)‐3‐nitrobenzamide derivatives as xanthine oxidase inhibitors through a non‐anthraquinone exploration	10
Synthesis, anticholinesterase activity, molecular docking, and molecular dynamic simulation studies of 1,3,4‐oxadiazole derivatives	10
Inhibitory effects of 190 compounds against SARS‐CoV‐2 M^pr^o protein: Molecular docking interactions	10
Synthesis, characterization, biochemical, and molecular modeling studies of carvacrol‐based new thiosemicarbazide and 1,3,4‐thiadiazole derivatives	10
	10
ω‐(5‐Phenyl‐2H‐tetrazol‐2‐yl)alkyl‐substituted hydrazides and related compounds as inhibitors of amine oxidase copper containing 3 (AOC3)	10
A novel indole derivative, 2‐{3‐[1‐(benzylsulfonyl)piperidin‐4‐yl]‐2‐methyl‐1H‐indol‐1‐yl}‐1‐(pyrrolidin‐1‐yl)ethenone, suppresses hedgehog signaling and drug‐resistant tumor growth	10
Multitargeted inhibition of key enzymes associated with diabetes and Alzheimer's disease by 1,3,4‐oxadiazole derivatives: Synthesis, in vitro screening, and computational studies	10
Editorial Board: Arch Pharm (9/2023)	10
Design, synthesis, and structure–activity studies of new rhodanine derivatives as carbonic anhydrase II, IX inhibitors	10
Targeting the binding pocket of the fluorophore 8‐anilinonaphthalene‐1‐sulfonic acid in the bacterial enzyme MurA	10
Тhio‐containing pteridines: Synthesis, modification, and biological activity	10
Deciphering Anticoagulant Active Substances and Mechanisms in Guanxinjing Formula Through Phenotype‐Anchored Hierarchical Strategy and Topological Network Analysis	10
Rational Design of 6‐Amino‐2‐Piperazinylpyridine‐Based ROCK2 Inhibitors With Anti‐Breast Cancer Metastatic Efficiency	10
Synthesis and biological evaluation of benzamide‐chalcone hybrids as potential c‐Met kinase and COX‐2 inhibitors	9
Structure Characterization and Antibacterial, Antifungal, and Antiquorum‐Sensing Activity of New Metabolites From the Lipophilic Fractions of Platycodon grandiflorum	9
Metabolic profiling of Verbena bonariensis L. extract by LC/MS and evaluation of the hepatoprotective potential with isoniazid‐ and rifampicin‐induced hepatotoxicity in rats	9
Proapoptotic effects of halogenated bis‐phenylthiourea derivatives in cancer cells	9
Development of new pyrazoles as class I HDAC inhibitors: Synthesis, molecular modeling, and biological characterization in leukemia cells	9
Xanthenone Orchestrates the Renin–Angiotensin System/Ferroptosis Crosstalk: A Novel AT2R‐Dependent Strategy Against Lower Limb Transient Ischemia‐Induced Liver Injury	9
An overview of the latest outlook of sulfamate derivatives as anticancer candidates (2020–2024)	9
Ginkgo biloba in the management of the COVID‐19 severity	9
Design, synthesis of novel thiazole‐thiomorpholine derivatives and evaluation of their anticancer activity via in vitro and in silico studies	9

Design, Synthesis, and Selective Antiproliferative Activity of Indolizine Derivatives as Microtubule Destabilizers	9
1,3,4‐Thiadiazole and 1,2,4‐triazole‐5‐thione derivatives bearing 2‐pentyl‐5‐phenyl‐2,4‐dihydro‐3H‐1,2,4‐triazole‐3‐one ring: Synthesis, molecular docking, urease inhibition, and crystal struct	9
Dihydropyrimidinones as potent anticancer agents: Insight into the structure–activity relationship	9
New phenylthiosemicarbazide‐phenoxy‐1,2,3‐triazole‐N‐phenylacetamides as dual inhibitors against α‐glucosidase and PTP‐1B for the treatment of type 2 diabetes	9
New 1,3,4‐Thiadiazole‐Based Dual B‐Raf/VEGFR‐2 Inhibitors With Potential Anti‐Breast Activity: Design, Synthesis, In Vitro and In Silico Evaluations	9
Beyond the Shadow of Indole: Medicinal Chemistry of Indolizines and Isoindolinones in the Fight Against Infectious Diseases	9
Greenness‐by‐design approach for developing novel UV spectrophotometric methodologies resolving a quaternary overlapping mixture	9
The carbonic anhydrase enzymes as new targets for the management of neglected tropical diseases	9
Issue Information: Arch Pharm (1/2025)	9
The anti‐breast cancer potential of indole/isatin hybrids	9
Self‐microemulsifying drug delivery system‐based gastroretentive in situ raft of pazopanib with enhanced solubility and bioavailability	9
Research progress on the pathogenesis of psoriasis and its small molecule inhibitors	9
Eco‐friendly approaches to 1,3,4‐oxadiazole derivatives: A comprehensive review of green synthetic strategies	9
Discovery of C2: A Novel Lead Compound for the Treatment of Gout and Hyperuricemia via Multi‐Pathway Inhibition	9
Synthesis, structure–activity relationship, and biological evaluation of quinolines for development of anticancer agents	9
New 1H‐indole‐2,3‐dione 3‐thiosemicarbazones with 3‐sulfamoylphenyl moiety as selective carbonic anhydrase inhibitors	9
Issue Information: Arch Pharm (12/2024)	9
Biological functions of kojic acid and its derivatives in medicine, cosmetics, and food industry: Insights into health aspects	8
Revealing a Gold Mine of Bioactive Compounds From Natural Sources Using In Vitro, In Silico, and Network Pharmacology: A Case Study on Cachrys cristata	8
The current landscape of coumarin hybrids with antibreast cancer therapeutic applications: An updated review	8
A review of recent advances in anticancer activity and SAR of pyrazole derivatives	8
3‐[3‐(Phenalkylamino)cyclohexyl]phenols: Synthesis, biological activity, and in silico investigation of a naltrexone‐derived novel class of MOR‐antagonists	8
Innovative Pyrazole–Thiazole–Oxadiazole Hybrid Compounds for Targeted EGFR/VEGFR2 Inhibition in Cancer Treatment	8
Harnessing Fragment Merging and Chain Extension Approaches for Designing Phthalimidoalkyl‐Arylidene Thiazolidinedione Hybrids: New Frontiers in Apoptosis‐Inducing Cancer Treatment	8
Editorial Board: Arch Pharm (9/2022)	8
Development and in vitro antiviral activity of ivermectin liposomes as a potential drug carrier system	8
Novel RP‐HPLC method for estimation of a newly developed combination of tizanidine and etoricoxib in rat plasma: Eight criteria for greens evaluation	8
4‐{3‐[(Pyridin‐4‐ylmethyl)amino]‐[1,2,4]triazolo[4,3‐b][1,2,4]triazin‐6‐yl}phenol: An improved anticancer agent in hepatocellular carcinoma and a selective MDR1/MRP modulator	8
Corrigendum to “Design, Synthesis, Biological Evaluation, and In Silico Studies of Quinoxaline Derivatives as Potent p38αMAPK Inhibitors”	8
Combating Drug‐Resistant Protozoal Infections: A Review of Emerging Therapeutics	8
Emerging green synthetic routes for thiazole and its derivatives: Current perspectives	8
Bruceantin and Brusatol: Molecular Insights and Therapeutic Promise of Quassinoids in Cancer Drug Discovery	8
Pyrazole scaffold‐based derivatives: A glimpse of α‐glucosidase inhibitory activity, SAR, and route of synthesis	8
Novel isoxazoline‐linked 1,3,4‐thiadiazole hybrids as anticancer agents: Design, synthesis, biological evaluation, molecular docking, and molecular dynamics simulation	8
Various pharmacological agents in the pipeline against intractable epilepsy	8
Development and Synthesis of Bioactive (3‐Arylediene‐1‐phenyl‐1 H ‐pyrazol‐4‐yl)acryloyl‐4‐hydroxy‐6‐methyl‐2 H	8
New [1,2,4]triazolo[4,3‐c]quinazoline derivatives as vascular endothelial growth factor receptor‐2 inhibitors and apoptosis inducers: Design, synthesis, docking, and antiproliferative evaluatio	8
	8
Nature‐Inspired Compounds Targeting Escherichia coli WrbA as Biofilm‐Modulating Agents: Computational Design, Synthesis, and Biological Evaluation	8
Cover Picture: Arch Pharm (10/2023)	8
EGB761 ameliorates mild cognitive impairment by inhibiting the pyroptosis and apoptosis in both in vivo and in vitro experiments	8
Cover Picture: Arch Pharm (8/2023)	8
Design, Synthesis and Evaluation of Indole‐Based 1,2,3‐Triazoles as Potential Quorum Sensing and Biofilm Inhibitors Against Pseudomonas aeruginosa	8
In‐vitro and in‐silico investigations of SLC‐0111 hydrazinyl analogs as human carbonic anhydrase I, II, IX, and XII inhibitors	8
Rational Design, Green Synthesis, and Biological Evaluation of Novel Imidazole Derivatives as Potent EGFR Inhibitors via One‐Pot Four‐Component Reaction	8
MCC950 as a promising candidate for blocking NLRP3 inflammasome activation: A review of preclinical research and future directions	8
Design and synthesis of benzofuran‐ and naphthalene‐fused thiazinones as antimycobacterial agents	8
Indoles—A Targeting the PI3K/Akt/mTOR Pathway: Recent Advances in Strategic Design, Mechanism, and Future Perspectives	8
Synthesis and evaluation of febrifugine derivatives as anticoccidial agents	8
Synthesis of new dihydropyrimidine derivatives and investigation of their antimicrobial and DNA gyrase inhibitory activities	8
Synthesis and biological evaluation of sulfonamide‐based compounds as inhibitors of carbonic anhydrase from Vibrio cholerae	8
Editorial Board: Arch Pharm (6/2022)	8
	8
A decade of research effort in synthesis, biological activity assessments, and mechanistic investigations of sulfamethazine‐incorporating molecules	7
Soft drug inhibitors for the epigenetic targets lysine‐specific demethylase 1 and histone deacetylases	7
Harnessing PHGDH Inhibition for Cancer Therapy: Mechanisms, SAR, Computational Aspects, and Clinical Potential	7
Morpholinodiazenyl chalcone blocks influenza A virus capsid uncoating by perturbing the clathrin‐mediated vesicular trafficking pathway	7
Development and molecular modeling studies of new thiadiazole piperazine urea derivatives as potential fatty acid amide hydrolase inhibitors	7
Support Vector Machine Identification of Small Molecule Binders to an Understudied Allosteric Site of SARS‐CoV‐2 Mpro for Next‐Generation PROTAC‐Based Therapeutics	7
	7
The effects of morin and methotrexate on pentose phosphate pathway enzymes and GR/GST/TrxR enzyme activities: An in vivo and in silico study	7
Discovery of new cyanopyridine/chalcone hybrids as dual inhibitors of EGFR/BRAF^V600E with promising antiproliferative properties	7
Design and synthesis of novel substituted s‐triazines tethered benzenesulfonamides as potential antimicrobial candidates: Antibiofilm and bacterial protein permeability assessments	7
Synthesis of selenophene‐based chalcone analogs and assessment of their biological activity as anticancer agents	7
Synthesis of benzylated amine‐substituted xanthone derivatives and their antioxidant and anti‐inflammatory activities	7
Design, synthesis, and biological evaluation of naphthalene imidazo[1,2‐b]pyridazine hybrid derivatives as VEGFR selective inhibitors	7
New azaaurone derivatives as potential multitarget agents in HIV‐TB coinfection	7
Design, Synthesis, and Biological Evaluation of Novel Benzimidazole/Schiff Base Hybrid Derivatives With Potential Biological Activities	7
Novel N‐pyrocatechoyl and N‐pyrogalloyl hydrazone antioxidants endowed with cytotoxic and antibacterial activity	7
1H‐1,2,3‐Triazole−4H‐chromene−D‐glucose hybrid compounds: Synthesis and inhibitory activity against Mycobacterium tuberculosis protein tyrosine phosphatase B	7
Development of Potent Type V MAPK Inhibitors: Design, Synthesis, and Biological Evaluation of Benzothiazole Derivatives Targeting p38α MAPK in Breast Cancer Cells	7
Structure‐Based Design of Chiral Thioureas as Anticholinesterase Inhibitors Using Enantiopure α‐Methylbenzylamines: Synthesis, Enzyme Inhibition, and In Silico Studies	7
Chicoric acid alleviates rotenone‐induced motor dysfunction in mice: Targeting PI3K/AKT/caspase‐3‐associated apoptosis and neuroinflammation	7
Exosomal miR‐122, miR‐128, miR‐200, miR‐298, and miR‐342 as novel diagnostic biomarkers in NAFL/NASH: Impact of LPS/TLR‐4/FoxO3 pathway	7
Quinolinone Derivatives Suppress Angiogenesis in Human Umbilical Vein Endothelial Cells by Blocking the VEGF‐Induced VEGFR2 Signaling Pathway	7
Multi‐Angle Bioactivity Cartography for Computational Screening and Mechanistic Analysis of AChE Inhibitors From Yellow Gastrodia elata	7
Exploring Novel Nitrofuryl‐1,3,4‐Thiadiazole‐Based Derivatives: Design, Synthesis, and Evaluation of In Vitro Leishmanicidal and Trypanocidal Activity	7
Novel Purine‐Based Natural Products as Inhibitors of Cholinesterases and Monoamine Oxidases Presenting Potential Multitarget Therapeutics Tackling Alzheimer's Disease	7
Identification of vilazodone as a novel plasminogen activator inhibitor to overcome Alzheimer's disease through virtual screening, molecular dynamics simulation, and biological evaluation	7
Introduction to artificial intelligence and deep learning using interactive electronic programming notebooks	7
Discovery of 2‐phenylquinazolines as potent Mycobacterium avium efflux pump inhibitors able to synergize with clarithromycin against clinical isolate	7
	6
Repurposing of 5‐nitrofuran‐3,5‐disubstituted isoxazoles: A thriving scaffold to antitrypanosomal agents	6
Editorial Board: Arch Pharm (3/2023)	6
Issue Information: Arch Pharm (3/2025)	6
Target repurposing unravels avermectins and derivatives as novel antibiotics inhibiting energy‐coupling factor transporters (ECFTs)	6
	6
Novel 2‐oxo‐2‐phenylethoxy and benzyloxy diaryl urea hybrids as VEGFR‐2 inhibitors: Design, synthesis, and anticancer evaluation	6
Cover Picture: Arch Pharm (11/2022)	6
6‐aryloxy‐2‐aminopyrimidine‐benzonitrile hybrids as anti‐infective agents: Synthesis, bioevaluation, and molecular docking	6
Multipathway regulation induced by 4‐(phenylsulfonyl)morpholine derivatives against triple‐negative breast cancer	6
	6
Uro‐Protective Role of Lacosamide Against Cyclophosphamide‐Induced Cystitis via Notch1/NICD/NF‐ κ B Pathway: Network Pharmacology, Molecular Docking, and	6
Editorial Board: Arch Pharm (2/2023)	6
Issue Information: Arch Pharm (11/2024)	6